top of page
shutterstock_631636766_edited.jpg

Transforming the Understanding
     of Trauma’s Impact

Trauma Autoimmune Indicator™ (TAI) Screening

How Does It Work?

Our TAI™ test uses RNA biomarker technology to analyze the body's response to stress. It measures biomarkers associated with inflammatory processes, providing healthcare professionals with objective data for consideration alongside a full clinical assessment. This information contributes to a broader understanding of individual wellness patterns.

TAI™ Screening Advantages

The TAI™ test provides information on biomarker levels that may be associated with stress response. It is designed for use by healthcare professionals as part of a comprehensive evaluation. The test process efficiently analyzes inflammatory biomarkers and can be adapted to various patient populations.

Precise Measurement of Inflammatory Biomarkers

Provides Actionable Biological Data

Designed for Widespread Clinical Use

Toward a New Understanding of Trauma's Impact

The profound effects of traumatic stress on long-term wellness are increasingly clear. While traditional approaches often focus on care after symptoms emerge, iXpressGenes is pioneering research into a different path.

Our research focuses on the biological response to stress. The iXpressGenes TAI™ test is a laboratory-developed test that measures specific biomarkers to provide objective data on the body's inflammatory and immune activity. This information is intended for use by healthcare providers as a single component of a broader clinical assessment, offering a biological perspective to inform a more complete picture of an individual's wellness.

Exploring New Approaches in Trauma Support

iXpressGenes is researching the biological impact of trauma. The TAI™ test is a laboratory-developed test that provides information on biomarker levels associated with the body's response to stress. This data is intended for consideration by healthcare professionals as part of a comprehensive clinical evaluation. Our goal is to contribute to a better understanding of trauma's effects on the body.

The TAI™ Sreening Process

Provider-Process-Graphic-individual.png
Provider-Process-Graphic-individual2.png
Provider-Process-Graphic-individual3.png
Provider-Process-Graphic-individual4_edited.png
Provider-Process-Graphic-individual5.png
Provider-Process-Graphic-individual6.png
iXpressGenes (iXG) Stacked Logo
687593.jpg
image (1).png

DISCLAIMER: iXpressGenes panels, including TAI™ and  APX™, were developed and its performance characteristics determined by iXpressGenes in its College of American Pathologists (CAP) accredited laboratory. They have not been cleared or approved by the U.S. Food and Drug Administration (FDA).   iXpressGenes Inc. is not a licensed medical provider.  iXpressGenes panels do not diagnose any disease or condition, including PTSD. The panels are not intended to inform treatment decisions. This test provides informational data on biomarker levels for consideration by a qualified healthcare professional within the full context of a patient's clinical evaluation.  All interpretations or information provided are derived from peer-reviewed scientific literature and are not a substitute for professional medical advice, diagnosis, or treatment. Patients must consult their physician or licensed healthcare provider before making any medical decisions.

info@ixpressgenes.com

601 Genome Way NW Suite 2023

Huntsville, AL 35806

Connect with us on:

  • LinkedIn
bottom of page